The PRISMA (Prospective, Randomized Trial on Intensive Self-Monitoring Blood Glucose Management Added Value in Non-Insulin Treated Type 2 Diabetes Mellitus Patients) trial demonstrated that intensive SMBG significantly enhances glycemic control and aids in managing type 2 diabetes [3]. This evidence concerns the gene INS and type 2 diabetes mellitus.